MarketWatch: Health Round-up
Pages: 53
Publisher: Datamonitor
Date Published: February 2006
Format: PDF
Price: $400
Overview
Datamonitor’s MarketWatch Health Round-up is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the Healthcare industry. The report contains the latest news, analysis and opinion, covering all the month’s major issues and events in R&D, regulatory and licensing in the Healthcare industry.
Table of Contents
In this month’s MarketWatch…
Pharmaceutical Company Round-up
Page 3
Cancer Update
Page 4 – News Round-up
Page 6 – Opinion: Genentech/Biogen Idec: wearing the drug marketing suit well?
Page 7 – Opinion: Celgene: Thalomid slows progression of multiple myeloma…
Page 8 – Opinion: Genentech/Roche: expanding Avastin’s empire…
Page 9 – Feature Analysis: Targeted cancer therapies: another step forward…
Cardiovascular Update
Page 11 – News Round-up
Page 14 – Opinion: Novartis: cardio refocus should reward…
Page 14 – Opinion: Pfizer: a triumph of the heart…
Page 15 – Opinion: Daiichi Sankyo: pipeline filling at the O-KAI Corral…
Page 17 – Feature Analysis: AstraZeneca on the acquisition trail…
CNS Update
Page 20 – News Round-up
Page 22 – Opinion: Johnson & Johnson: paliperidone shows pivotal promise…
Page 23 – Opinion: ADHD: attending to safety deficits …
IDI Update
Page 24 – News Round-up
Page 26 – Feature Analysis: AstraZeneca’s Symbicort gives asthma patients the power to get SMART…
Infectious Diseases Update
Page 29 – News Round-up
Page 32 – Opinion: Roche: Tamiflu targeted by counterfeiters…
Page 33 – Opinion: Idenix/Novartis: filing for hepatitis hope…
Page 34 – Opinion: Gilead: moving HIV hope forward…
Company Spotlight
Page 35 – Pfizer Inc
Biotechnology Update
Page 43 – Biotech News Round-up
Company Spotlight
Page 45 – Bayer AG
Index
Page 52 – Pharma companies
Page 52 – Biotech companies
Page 53 – Key drugs
